Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial (Q39297779)

10 September 2017

title

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial (English)

1 reference

10 September 2017

0 references

0 references

Ronald R Holden

0 references

Alan C Jackson

0 references

Ian Gilron

1 reference

10 September 2017

Joan M Bailey

series ordinal

1 reference

10 September 2017

Dongsheng Tu

series ordinal

1 reference

10 September 2017

Robyn L Houlden

series ordinal

1 reference

10 September 2017

language of work or name

English

0 references

publication date

30 September 2009

1 reference

10 September 2017

1 reference

10 September 2017

volume

374

1 reference

10 September 2017

issue

9697

1 reference

10 September 2017

page(s)

1252-1261

1 reference

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Prevalence of chronic pain with neuropathic characteristics in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Neuropathic pain: redefinition and a grading system for clinical and research purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Clinical characteristics and economic costs of patients with painful neuropathic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Pharmacologic management of neuropathic pain: evidence-based recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

The short-form McGill Pain Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Combination therapy for neuropathic pain--which drugs, which combination, which patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

New treatments for neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Combination pharmacotherapy for neuropathic pain: current evidence and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

An overview of drug combination analysis with isobolograms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

A beneficial effect on mood in partial epilepsy patients treated with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961081-3

7 January 2021

10.1016/S0140-6736(09)61081-3

Identifiers

DOI

1 reference

10 September 2017

1 reference